CNBCLean R·
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
Read at CNBC →
Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
<iframe src="https://statesidedaily.com/embed/cluster/115d13df7b6e36bf305a8b86a00b07136d04b148" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges"></iframe>